Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Curtis Mark Rimmerman, MD, MBA, is a staff cardiologist in the Section of Clinical Cardiology, the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is also Director of the Cleveland Clinic Cardiovascular Medicine Affiliate Programs. He holds the Gus P. Karos Endowed Chair in Clinical Cardiovascular Medicine, awarded in 2001.
Specialty/Clinical interests: Coronary artery disease, valvular heart disease, congestive heart failure, cardiac arrhythmias, lipid abnormalities, and cardiovascular medicine prevention.
Success Rates: Cleveland Clinic has been ranked the #1 hospital for cardiology and heart surgery by U.S. News & World Report since 1994. Success rates for specific procedures are available at: http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx
Education and Training: Dr. Rimmerman was raised in Cleveland, Ohio. He completed his undergraduate studies at Case Western Reserve University, graduating Magna Cum Laude with a degree in chemistry (Phi Beta Kappa). He received his medical degree from the Case Western Reserve University School of Medicine. Dr. Rimmerman completed his internship and residency in internal medicine at Vanderbilt University Medical Center in Nashville, Tenn., followed by a cardiology fellowship at the Krannert Institute of Cardiology at Indiana University Medical Center, Indianapolis. He continued his education while on the professional Staff at Cleveland Clinic at the Case Western Reserve University Weatherhead School of Management, earning a Master's Degree in Business Administration. Dr. Rimmerman was appointed to the professional Staff of Cleveland Clinic in 1993.
Research and Publications: Dr. Rimmerman has organized and chaired conferences and symposia, with an emphasis on topics related to electrocardiography and echocardiography. He has published articles and abstracts in leading medical journals and authored or co-authored chapters in medical textbooks related to interactive electrocardiography, acute coronary syndromes and myocardial infarction. His Interactive Electrocardiography CD-ROM and Workbook serves as an industry standard for electrocardiography education.
Dr. Rimmerman has published two books with Kaplan Publishing. His first book, The Cleveland Clinic Guide to Heart Attacks, was released in 2009. A second book, The Cleveland Clinic Guide to Speaking With Your Cardiologist, was released in 2010.
About Dr. Rimmerman: “My greatest strengths are my consistent dedication to the best interests of my patients, timely and responsible communication, and an empathetic and patient approach.”
Leisure Activities: In his spare time, Dr. Rimmerman enjoys spending time with his family, international travel, landscaping, exercising and reading.
General cardiology, heart disease, coronary artery disease, echocardiogram, electrocardiogram, exercise stress echocardiogram, high cholesterol
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/25/2015, Dr. Rimmerman has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.